Patents by Inventor Xiran Qiu

Xiran Qiu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIGEN-BINDING PROTEIN TARGETING PNEUMOLYSIN AND USE THEREOF
    Publication number: 20240174736
    Abstract: Provided is an isolated antigen-binding protein, which comprises at least one CDR in an antibody heavy chain variable region VH, wherein the VH comprises the amino acid sequence as shown in SEQ ID NO: 39. The isolated antigen-binding protein can specifically bind to pneumolysin protein and variants thereof. Further provided is the use of the isolated antigen-binding protein in prevention and/or treatment of diseases and/or conditions of a Streptococcus pneumoniae infection.
    Type: Application
    Filed: March 21, 2022
    Publication date: May 30, 2024
    Applicants: Starmab Biologics (Suzhou) Co., Ltd, Starmab Biologics (Shanghai) Co., Ltd
    Inventors: Maomao An, Shiyu Guo, Simin Chen, Xiran Qiu, Bohua Li
  • ANTIGEN-BINDING PROTEIN TARGETING STAPHYLOCOCCUS AUREUS a-HEMOLYSIS AND APPLICATION THEREOF
    Publication number: 20240059764
    Abstract: The present invention relates to the field of biomedicine, and provides an isolated antigen-binding protein and a derived protein thereof, which can specifically bind to Staphylococcus aureus ? toxin and neutralize the biological activity thereof. Also provided is a use of the isolated antigen-binding protein and derived protein thereof in the field of treating and/or preventing Staphylococcus aureus infection.
    Type: Application
    Filed: January 11, 2022
    Publication date: February 22, 2024
    Applicants: Starmab Biologics (suzhou) Co., Ltd., Starshining Biologics (Shanghai) Co., Ltd.
    Inventors: Maomao An, Xiran Qiu, Simin Chen, Shiyu Guo, Bohua Li